{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:03:12Z","timestamp":1794661392617,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":213,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01\\u2014NS103475"],"award-info":[{"award-number":["U01\\u2014NS103475"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01\\u2014NS040068"],"award-info":[{"award-number":["R01\\u2014NS040068"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01\\u2014NS105509"],"award-info":[{"award-number":["U01\\u2014NS105509"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005071","name":"Shiraz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-3433"],"award-info":[{"award-number":["A-3433"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["606,650"],"award-info":[{"award-number":["606,650"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.nicl.2024.103650","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T12:04:29Z","timestamp":1723291469000},"page":"103650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Prognostic enrichment for early-stage Huntington\u2019s disease: An explainable machine learning approach for clinical trial"],"prefix":"10.1016","volume":"43","author":[{"given":"Mohsen","family":"Ghofrani-Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govinda R.","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Razi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pubu M.","family":"Abeyasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellie","family":"Georgiou-Karistianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nicl.2024.103650_b0005","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/mds.28650","article-title":"Tracking Huntington\u02bcs disease progression using motor, functional, cognitive, and imaging markers","volume":"36","author":"Abeyasinghe","year":"2021","journal-title":"Mov. Disord."},{"issue":"July","key":"10.1016\/j.nicl.2024.103650_b0010","article-title":"Utility of Huntington\u2019s disease assessments by disease stage: floor\/ceiling effects","volume":"12","author":"Abreu","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nicl.2024.103650_b0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13246-019-00754-5","article-title":"A knowledge-based system for brain tumor segmentation using only 3D FLAIR images","volume":"42","author":"Amirmoezzi","year":"2019","journal-title":"Australas. Phys. Eng. Sci. Med."},{"issue":"7","key":"10.1016\/j.nicl.2024.103650_b0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.drudis.2014.03.002","article-title":"Biomarker development for Huntington\u2019s disease","volume":"19","author":"Andre","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12030435","article-title":"A clinical decision support system for the prediction of quality of life in ALS","volume":"12","author":"Antoniadi","year":"2022","journal-title":"J Pers Med."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WAD.0b013e3182677b3d","article-title":"Ventricular atrophy and its clinical correlates in the imaging cohort from the ADCS MCI Donepezil\/Vitamin E study","volume":"27","author":"Apostolova","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"7906","key":"10.1016\/j.nicl.2024.103650_b0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-022-04554-y","article-title":"Brain charts for the human lifespan","volume":"604","author":"Bethlehem","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nicl.2024.103650_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119083","article-title":"Ten years of image analysis and machine learning competitions in dementia","volume":"253","author":"Bron","year":"2022","journal-title":"Neuroimage"},{"issue":"19","key":"10.1016\/j.nicl.2024.103650_b0045","first-page":"443","article-title":"Baseline multimodal information predicts future motor impairment in premanifest Huntington\u2019s disease","volume":"2018","author":"Castro","year":"2017","journal-title":"NeuroImage Clin."},{"issue":"12","key":"10.1016\/j.nicl.2024.103650_b0050","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/mds.29219","article-title":"Predictive modeling of huntington\u2019s disease unfolds thalamic and caudate atrophy dissociation","volume":"37","author":"Castro","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2024.103650_b0055","article-title":"Patterns of co-occurring gray matter concentration loss across the huntington disease prodrome","volume":"7(SEP):1\u201314","author":"Ciarochi","year":"2016","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.nicl.2024.103650_b0060","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awab108","article-title":"Towards realizing the vision of precision medicine: AI based prediction of clinical drug response","volume":"144","author":"de Jong","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0065","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.nicl.2024.103650_b0070","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/mds.28489","article-title":"Composite UHDRS correlates with progression of imaging biomarkers in huntington\u2019s disease","volume":"36","author":"Estevez-Fraga","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-240017","article-title":"Huntington\u2019s disease clinical trials corner: march 2024","volume":"13","author":"Estevez-Fraga","year":"2024","journal-title":"J. Huntingtons Dis."},{"issue":"8","key":"10.1016\/j.nicl.2024.103650_b0080","first-page":"908","article-title":"Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products guidance for industry","volume":"29","author":"FDA","year":"2019","journal-title":"FDA Guid Ind."},{"key":"10.1016\/j.nicl.2024.103650_b0085","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Food Drug Adm. Published online 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK338448\/."},{"issue":"May","key":"10.1016\/j.nicl.2024.103650_b0090","first-page":"6","article-title":"Ranking the predictive power of clinical and biological features associated with disease progression in huntington\u2019s disease","volume":"12","author":"Ghazaleh","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nicl.2024.103650_b0095","first-page":"92","article-title":"An exploration of latent structure in observational huntington\u2019s disease studies","volume":"2017","author":"Ghosh","year":"2017","journal-title":"AMIA Jt Summits Transl. Sci. Proceedings AMIA Jt Summits Transl. Sci."},{"issue":"5","key":"10.1016\/j.nicl.2024.103650_b0100","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/jmri.27203","article-title":"Longitudinal structural MRI in neurologically healthy adults","volume":"52","author":"Gregory","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2024.103650_b0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/9781118661895.ch21","article-title":"Huntington\u2019s disease and other choreas","author":"Haider","year":"2017","journal-title":"Neurodegeneration. Published Online"},{"key":"10.1016\/j.nicl.2024.103650_b0110","doi-asserted-by":"crossref","unstructured":"Hamdan, S., Love, B.C., von Polier, G.G., et al., 2022. Confound-leakage: Confound Removal in Machine Learning Leads to Leakage. arXiv Prepr arXiv221009232. Published online 2022.","DOI":"10.1093\/gigascience\/giad071"},{"key":"10.1016\/j.nicl.2024.103650_b0115","doi-asserted-by":"crossref","unstructured":"Hawellek, D.J., Engemann, D.A., Holiga, S., Napolitano, A., Abaei, M., McColgan, P., 2022. E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington\u2019s disease (HD) based on the tominersen phase III trial generation HD 1. In: E: Imaging. Vol 93. BMJ Publishing Group Ltd; 2022:A35.1-A35. doi:10.1136\/jnnp-2022-ehdn.86.","DOI":"10.1136\/jnnp-2022-ehdn.86"},{"issue":"6","key":"10.1016\/j.nicl.2024.103650_b0120","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A2018","article-title":"Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study","volume":"31","author":"Hobbs","year":"2010","journal-title":"Am. J. Neuroradiol."},{"issue":"11","key":"10.1016\/j.nicl.2024.103650_b0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14737175.2020.1801424","article-title":"Expert review of neurotherapeutics gene therapy and immunotherapy as promising strategies to combat Huntington \u2019 s disease- associated neurodegeneration : emphasis on recent updates and future perspectives","volume":"20","author":"Jamwal","year":"2020","journal-title":"Expert Rev. Neurother."},{"issue":"9","key":"10.1016\/j.nicl.2024.103650_b0130","first-page":"16","volume":"8","author":"Jfd","year":"2013","journal-title":"Multi-Modal Neuroimaging in Premanifest and Early Huntington \u2019 s Disease: 18 Month Longitudinal Data from the IMAGE-HD Study."},{"key":"10.1016\/j.nicl.2024.103650_b0135","unstructured":"JNPD Research and Innovation Strategy.; 2019. https:\/\/www.neurodegenerationresearch.eu\/initiatives\/the-2018-jpnd-research-and-innovation-strategy\/."},{"issue":"8","key":"10.1016\/j.nicl.2024.103650_b0140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biopsych.2020.11.009","article-title":"Archival report dynamics of cortical degeneration over a decade in Huntington \u2019 s disease","volume":"89","author":"Johnson","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.nicl.2024.103650_b0145","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biopsych.2020.11.009","article-title":"Dynamics of cortical degeneration over a decade in Huntington\u2019s disease","volume":"89","author":"Johnson","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2024.103650_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2023.107495","article-title":"Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson\u2019s disease","volume":"234","author":"Junaid","year":"2023","journal-title":"Comput. Methods Programs Biomed."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-05583-3","article-title":"Effect of head motion-induced artefacts on the reliability of deep learning-based whole-brain segmentation","volume":"12","author":"Kemenczky","year":"2022","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.nicl.2024.103650_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168363","article-title":"New avenues for the treatment of huntington\u2019s disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nicl.2024.103650_b0165","doi-asserted-by":"crossref","unstructured":"Kinnunen, K.M., Mullin, A.P., Pustina, D., et al., 2021. Recommendations to Optimize the Use of Volumetric MRI in Huntington \u2019 s Disease Clinical Trials;12(October). doi:10.3389\/fneur.2021.712565.","DOI":"10.3389\/fneur.2021.712565"},{"issue":"September","key":"10.1016\/j.nicl.2024.103650_b0170","article-title":"Volumetric MRI-based biomarkers in Huntington\u2019s disease: an evidentiary review","volume":"12","author":"Kinnunen","year":"2021","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.nicl.2024.103650_b0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ebiom.2015.08.002","article-title":"Compensation in preclinical Huntington\u2019s disease: evidence from the track-On HD study","volume":"2","author":"Kl\u00f6ppel","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nicl.2024.103650_b0180","article-title":"E13 Predicting Huntington\u2019s disease state using structural MRI: it\u2019s more than just the striatum","author":"Kohli","year":"2022","journal-title":"Published Online"},{"key":"10.1016\/j.nicl.2024.103650_b0185","article-title":"Predicting Huntington \u2019 s disease state with ensemble learning & sMRI : more than just the striatum","author":"Kohli","year":"2023","journal-title":"Published Online"},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2021.100198","article-title":"Latent representation learning in biology and translational medicine","volume":"2","author":"Kopf","year":"2021","journal-title":"Patterns."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0195","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1038\/s41598-022-18848-8","article-title":"Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials","volume":"12","author":"Koval","year":"2022","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.nicl.2024.103650_b0200","article-title":"Cortical neurodevelopment in pre-manifest Huntington\u2019s disease","volume":"2019","author":"Kubera","year":"2018","journal-title":"NeuroImage Clin."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington Disease (HD): a review and validation study of statistical approaches","volume":"153","author":"Langbehn","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"issue":"5","key":"10.1016\/j.nicl.2024.103650_b0210","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/mds.28944","article-title":"Utility of the Huntington\u2019s disease prognostic index score for a perimanifest clinical trial","volume":"37","author":"Langbehn","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2024.103650_b0215","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12732","article-title":"Putting participants and study partners FIRST when clinical trials end early","author":"Largent","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5","key":"10.1016\/j.nicl.2024.103650_b0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","article-title":"Genetic modifiers of Huntington disease differentially influence motor and cognitive domains","volume":"109","author":"Lee","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0225","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.26838","article-title":"Validation of a prognostic index for Huntington\u2019s disease","volume":"32","author":"Long","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JHD-220555","article-title":"Applying the Huntington\u2019s disease integrated staging system (HD-ISS) to observational studies","volume":"12","author":"Long","year":"2023","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nicl.2024.103650_b0235","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process Syst."},{"key":"10.1016\/j.nicl.2024.103650_b0240","doi-asserted-by":"crossref","unstructured":"Lundervold, A.J., Vik, A., Lundervold, A., 2019. Lateral ventricle volume trajectories predict response inhibition in older age\u2014a longitudinal brain imaging and machine learning approach. J\u00e4ncke L, ed. PLoS One; 14(4):e0207967. doi:10.1371\/journal.pone.0207967.","DOI":"10.1371\/journal.pone.0207967"},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0245","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41467-022-35712-5","article-title":"Forecasting individual progression trajectories in Alzheimer\u2019s disease","volume":"14","author":"Maheux","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nicl.2024.103650_b0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2017.03.012","article-title":"Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson\u2019s disease","volume":"55","author":"Mak","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0255","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.25171","article-title":"Predicting clinical diagnosis in Huntington\u2019s disease: an imaging polymarker","volume":"83","author":"Mason","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2024.103650_b0260","doi-asserted-by":"crossref","unstructured":"McColgan P, Gregory S, Zeun P, et al. Neurofilament light associated connectivity in young-adult Huntington\u2019s disease is related to neuronal genes. Brain. Published online June 27, 2022:awac227. doi:10.1093\/brain\/awac227.","DOI":"10.1093\/brain\/awac227"},{"issue":"23","key":"10.1016\/j.nicl.2024.103650_b0265","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc2300400","article-title":"Tominersen in adults with manifest Huntington\u2019s disease","volume":"389","author":"McColgan","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mds.28943","article-title":"Using big data in movement disorders: disease states and progression in Huntington\u2019s disease","volume":"37","author":"Mestre","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2024.103650_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.compmedimag.2021.101910","article-title":"A predictive framework based on brain volume trajectories enabling early detection of Alzheimer\u2019s disease","volume":"90","author":"Mofrad","year":"2021","journal-title":"Comput. Med. Imaging Graph."},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0280","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mds.28866","article-title":"A machine-learning derived Huntington\u2019s disease progression model: insights for clinical trial design","volume":"37","author":"Mohan","year":"2022","journal-title":"Mov. Disord."},{"issue":"63","key":"10.1016\/j.nicl.2024.103650_b0285","first-page":"179","article-title":"Combined cerebral atrophy score in Huntington\u2019s disease based on atlas-based MRI volumetry: sample size calculations for clinical trials","volume":"2019","author":"M\u00fcller","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Pt 9","key":"10.1016\/j.nicl.2024.103650_b0290","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database","volume":"131","author":"Nestor","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2024.103650_b0295","article-title":"Dose range finding study with open-label extension to evaluate the safety of Oral LMI070\/branaplam in early manifest huntington\u2019s disease (VIBRANT-HD)","author":"Novartis-Pharmaceuticals","year":"2021","journal-title":"Published Online"},{"issue":"May","key":"10.1016\/j.nicl.2024.103650_b0300","first-page":"1","article-title":"Targeted screening for alzheimer\u2019s disease clinical trials using data-driven disease progression models","volume":"5","author":"Oxtoby","year":"2022","journal-title":"Front. Artif. Intell."},{"key":"10.1016\/j.nicl.2024.103650_b0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2022.02.023","article-title":"Associations between prognostic index scores and plasma neurofilament light in Huntington\u2019s disease","volume":"97","author":"Parkin","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.nicl.2024.103650_b0310","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"10.1016\/j.nicl.2024.103650_b0315","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/mds.23337","article-title":"Challenges assessing clinical endpoints in early Huntington disease","volume":"25","author":"Paulsen","year":"2010","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.nicl.2024.103650_b0320","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp-2013-305114","article-title":"Group C of the HS. Cognitive decline in prodromal Huntington disease: implications for clinical trials","volume":"84","author":"Paulsen","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.nicl.2024.103650_b0325","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington\u2019s disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mds.27595","article-title":"Sample enrichment for clinical trials to show delay of onset in huntington disease","volume":"34","author":"Paulsen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2024.103650_b0335","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"issue":"8","key":"10.1016\/j.nicl.2024.103650_b0340","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","article-title":"Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy","volume":"27","author":"Peng","year":"2005","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"10.1016\/j.nicl.2024.103650_b0345","doi-asserted-by":"crossref","unstructured":"Petracca, M., Pontillo, G., Cocozza, S., et al., 2020. Estimating brain atrophy in clinical settings: linear measures of ventricular enlargement for evaluation of disease activity and long-term disability progression in Multiple Sclerosis (2121). Published online 2020.","DOI":"10.1212\/WNL.94.15_supplement.2121"},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58074-8","article-title":"Resting-state connectivity stratifies premanifest Huntington\u2019s disease by longitudinal cognitive decline rate","volume":"10","author":"Polosecki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nicl.2024.103650_b0355","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.01.013","article-title":"White matter connectivity reflects clinical and cognitive status in Huntington\u2019s disease","volume":"65","author":"Poudel","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nicl.2024.103650_b0360","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","article-title":"Longitudinal change in white matter microstructure in Huntington\u2019s disease: the IMAGE-HD study","volume":"74","author":"Poudel","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"14","key":"10.1016\/j.nicl.2024.103650_b0365","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1002\/hbm.24695","article-title":"Network spread determines severity of degeneration and disconnection in Huntington\u2019s disease","volume":"40","author":"Poudel","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2024.103650_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106043","article-title":"Explainable, trustworthy, and ethical machine learning for healthcare: a survey","volume":"149","author":"Rasheed","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(18)30391-0","article-title":"Safety and efficacy of pridopidine in patients with Huntington\u2019s disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study","volume":"18","author":"Reilmann","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2024.103650_b0380","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","article-title":"Highly accurate inverse consistent registration: a robust approach","volume":"53","author":"Reuter","year":"2010","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.nicl.2024.103650_b0385","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1212\/WNL.0000000000000187","article-title":"PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease","volume":"82","author":"Rosas","year":"2014","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nicl.2024.103650_b0390","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.patcog.2005.11.001","article-title":"Incremental wrapper-based gene selection from microarray data for cancer classification","volume":"39","author":"Ruiz","year":"2006","journal-title":"Pattern Recogn."},{"issue":"6","key":"10.1016\/j.nicl.2024.103650_b0395","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","article-title":"Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington\u2019s disease Young Adult Study (HD-YAS): a cross-sectional analysis","volume":"19","author":"Scahill","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2024.103650_b0400","article-title":"E01 The HD young adult study 2: longitudinal follow up","author":"Scahill","year":"2022","journal-title":"Published Online"},{"key":"10.1016\/j.nicl.2024.103650_b0405","first-page":"4","article-title":"Predicting severity of Huntington\u2019s disease with wearable sensors","author":"Scheid","year":"2022","journal-title":"Front Digit Heal."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0410","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18037-z","article-title":"Different scaling of linear models and deep learning in UKBiobank brain images versus machine-learning datasets","volume":"11","author":"Schulz","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0415","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s13311-021-01027-4","article-title":"The use, standardization, and interpretation of brain imaging data in clinical trials of neurodegenerative disorders","volume":"18","author":"Schwarz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nicl.2024.103650_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117751","article-title":"A gyrification analysis approach based on Laplace Beltrami eigenfunction level sets","volume":"229","author":"Shishegar","year":"2021","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: Clinical care and evaluation","volume":"29","author":"Shoulson","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2024.103650_b0430","first-page":"9","article-title":"Brain aging comprises many modes of structural and functional change with distinct genetic and biophysical associations","author":"Smith","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.nicl.2024.103650_b0435","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/hbm.26125","article-title":"Comprehensive shape analysis of the cortex in Huntington\u2019s disease","volume":"44","author":"Stoebner","year":"2023","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.nicl.2024.103650_b0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1037\/a0016973","article-title":"An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests","volume":"14","author":"Strobl","year":"2009","journal-title":"Psychol. Methods"},{"issue":"9","key":"10.1016\/j.nicl.2024.103650_b0445","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2024.103650_b0450","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.nicl.2024.103650_b0455","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.nicl.2024.103650_b0460","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington\u2019s disease: the integrated staging system","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2024.103650_b0465","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2024.103650_b0470","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/ene.14648","article-title":"Cortical morphometry and neural dysfunction in Huntington\u2019s disease: a review","volume":"28","author":"Tan","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nicl.2024.103650_b0475","article-title":"Safety and proof-of-concept (POC) Study with AMT-130 in adults with early manifest Huntington disease","author":"UniQure Biopharma","year":"2019","journal-title":"Published Online"},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0480","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","article-title":"Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease","volume":"258","author":"Van Den Bogaard","year":"2011","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2024.103650_b0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-200394","article-title":"The neurodevelopmental hypothesis of Huntington\u2019s disease","volume":"9","author":"Van Der Plas","year":"2020","journal-title":"J. Huntingtons Dis."},{"issue":"2","key":"10.1016\/j.nicl.2024.103650_b0490","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JHD-210475","article-title":"Standardizing the CAP score in huntington\u2019s disease by predicting age-at-onset","volume":"11","author":"Warner","year":"2022","journal-title":"J Huntingtons Dis."},{"issue":"12","key":"10.1016\/j.nicl.2024.103650_b0495","doi-asserted-by":"crossref","first-page":"e01457","DOI":"10.1002\/brb3.1457","article-title":"White matter hypointensities and hyperintensities have equivalent correlations with age and CSF \u03b2-amyloid in the nondemented elderly","volume":"9","author":"Wei","year":"2019","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.nicl.2024.103650_b0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10548-012-0246-x","article-title":"Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer\u2019s disease and mild cognitive impairment","volume":"26","author":"Westman","year":"2013","journal-title":"Brain Topogr."},{"key":"10.1016\/j.nicl.2024.103650_b0505","first-page":"751","article-title":"Robust markers and sample sizes for multicenter trials of huntington disease","author":"Wijeratne","year":"2020","journal-title":"Published Online"},{"issue":"August","key":"10.1016\/j.nicl.2024.103650_b0510","first-page":"1","article-title":"A Multi-study model-based evaluation of the sequence of imaging and clinical biomarker changes in Huntington\u2019s disease","volume":"4","author":"Wijeratne","year":"2021","journal-title":"Front Big Data."},{"key":"10.1016\/j.nicl.2024.103650_b0515","doi-asserted-by":"crossref","DOI":"10.1162\/imag_a_00010","article-title":"The temporal event-based model: learning event timelines in progressive diseases","author":"Wijeratne","year":"2023","journal-title":"Imaging Neurosci."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158224000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158224000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:46:32Z","timestamp":1773708392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158224000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":103,"alternative-id":["S2213158224000895"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2024.103650","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic enrichment for early-stage Huntington\u2019s disease: An explainable machine learning approach for clinical trial","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2024.103650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103650"}}